Latest Ratios: P/E Ratio -7.4x · EV/EBITDA 20.1x · ROE -90.2%. (2012–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.8B | $1.8B | $2.5B | $4.7B | $4.8B | $5.7B | $4.1B | $3.0B | $5.2B | $9.6B | $4.1B |
| Enterprise Value | $6.7B | $5.7B | $6.2B | $7.8B | $7.6B | $8.2B | $7.3B | $6.5B | $7.9B | $12.1B | $6.7B |
| P/E Ratio → | -7.36 | — | 29.65 | — | 8.39 | 9.32 | 18.78 | — | 5.18 | 12.80 | 552.25 |
| P/S Ratio | 0.49 | 0.31 | 0.44 | 0.77 | 0.71 | 0.89 | 0.83 | 0.54 | 0.78 | 1.55 | 0.75 |
| P/B Ratio | 11.31 | 7.07 | 4.19 | 6.36 | 4.38 | 5.23 | 5.06 | 4.29 | 5.05 | 11.05 | 38.96 |
| P/FCF | 55.47 | 34.80 | — | 25.25 | 10.82 | 10.54 | 7.64 | 17.64 | 8.03 | 41.93 | 15.83 |
| P/OCF | 10.72 | 6.72 | — | 8.45 | 6.42 | 6.96 | 5.11 | 4.59 | 4.52 | 14.96 | 6.82 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.98 | 1.07 | 1.28 | 1.12 | 1.29 | 1.47 | 1.18 | 1.19 | 1.96 | 1.24 |
| EV / EBITDA | 20.13 | 16.98 | 8.30 | 42.35 | 7.08 | 8.27 | 9.50 | 9.10 | 5.23 | 9.01 | 17.61 |
| EV / EBIT | — | — | 15.80 | — | 8.43 | 9.52 | 16.32 | 14.56 | 6.29 | 10.76 | 32.18 |
| EV / FCF | — | 111.53 | — | 41.90 | 17.02 | 15.27 | 13.51 | 38.52 | 12.34 | 53.14 | 26.15 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 15.5% | 15.5% | 19.9% | 21.5% | 23.7% | 21.8% | 21.5% | 19.2% | 29.7% | 28.4% | 20.6% |
| Operating Margin | -0.1% | -0.1% | 7.7% | -2.0% | 11.5% | 10.6% | 9.0% | 8.1% | 18.6% | 17.3% | 1.8% |
| Net Profit Margin | -6.6% | -6.6% | 1.5% | -3.9% | 8.5% | 9.6% | 4.4% | -0.9% | 15.0% | 12.1% | 0.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -90.2% | -90.2% | 12.8% | -25.8% | 52.8% | 64.1% | 29.0% | -6.1% | 105.6% | 154.0% | 6.0% |
| ROA | -5.2% | -5.2% | 1.1% | -3.0% | 7.6% | 8.3% | 3.1% | -0.7% | 13.6% | 11.2% | 0.1% |
| ROIC | -0.1% | -0.1% | 8.2% | -2.4% | 15.7% | 13.3% | 8.2% | 8.4% | 25.6% | 26.1% | 2.2% |
| ROCE | -0.1% | -0.1% | 7.7% | -2.1% | 13.7% | 11.9% | 7.9% | 7.9% | 21.8% | 21.6% | 2.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 18.27 | 18.27 | 7.20 | 5.82 | 3.50 | 3.68 | 5.25 | 6.43 | 3.89 | 4.75 | 34.08 |
| Debt / EBITDA | 13.69 | 13.69 | 5.85 | 23.36 | 3.60 | 4.02 | 5.57 | 6.25 | 2.62 | 3.06 | 9.33 |
| Net Debt / Equity | — | 15.59 | 6.02 | 4.19 | 2.51 | 2.34 | 3.89 | 5.08 | 2.72 | 2.95 | 25.40 |
| Net Debt / EBITDA | 11.68 | 11.68 | 4.90 | 16.83 | 2.58 | 2.56 | 4.13 | 4.93 | 1.83 | 1.90 | 6.95 |
| Debt / FCF | — | 76.73 | — | 16.65 | 6.20 | 4.72 | 5.87 | 20.88 | 4.32 | 11.21 | 10.32 |
| Interest Coverage | -0.03 | -0.03 | 1.48 | -0.53 | 5.55 | 4.65 | 2.13 | 2.15 | 6.46 | 5.24 | 0.95 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.78 | 1.78 | 1.68 | 1.54 | 1.70 | 1.80 | 1.83 | 1.80 | 1.93 | 2.12 | 1.44 |
| Quick Ratio | 0.85 | 0.85 | 0.86 | 1.00 | 0.96 | 1.21 | 1.17 | 1.10 | 1.26 | 1.55 | 1.01 |
| Cash Ratio | 0.40 | 0.40 | 0.40 | 0.48 | 0.58 | 0.78 | 0.77 | 0.61 | 0.70 | 0.94 | 0.51 |
| Asset Turnover | — | 0.79 | 0.77 | 0.74 | 0.89 | 0.84 | 0.70 | 0.76 | 0.90 | 0.85 | 0.89 |
| Inventory Turnover | 3.13 | 3.13 | 3.15 | 3.53 | 3.71 | 4.52 | 4.16 | 4.14 | 4.07 | 4.74 | 5.59 |
| Days Sales Outstanding | — | 42.67 | 48.61 | 36.63 | 33.45 | 41.42 | 37.54 | 44.52 | 47.34 | 54.25 | 54.55 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.7% | 4.4% | 5.8% | 3.2% | 3.2% | 2.9% | 4.0% | 5.5% | 2.9% | 0.2% | 0.5% |
| Payout Ratio | — | — | 172.1% | — | 26.6% | 27.0% | 74.9% | — | 14.9% | 2.9% | 314.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 3.4% | — | 11.9% | 10.7% | 5.3% | — | 19.3% | 7.8% | 0.2% |
| FCF Yield | 1.8% | 2.9% | — | 4.0% | 9.2% | 9.5% | 13.1% | 5.7% | 12.5% | 2.4% | 6.3% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 1.5% | 10.2% | 3.1% | 0.0% | 10.8% | 12.5% | 1.1% | 0.0% |
| Total Shareholder Yield | 2.7% | 4.4% | 5.8% | 4.6% | 13.4% | 6.0% | 4.0% | 16.3% | 15.4% | 1.3% | 0.5% |
| Shares Outstanding | — | $151M | $150M | $149M | $158M | $169M | $166M | $165M | $183M | $191M | $183M |
Legacy environmental liability overhang
According to current market data, the company trades at a negative trailing P/E of -8.10 and a P/FCF of 61.03, suggesting that investors are struggling to reconcile the firm's depressed earnings profile with the potential long-term value of its specialized fluoropolymer and refrigerant product portfolio.
The forward P/E of 14.78 implies that the market is pricing in a significant recovery in profitability, yet this optimism appears disconnected from the persistent volatility in the Titanium Technologies segment. Given the high EV/EBITDA of 20.97, the valuation appears stretched relative to peers, suggesting that the market may be overestimating the speed of the transition to higher-margin HFO products.
Based on reported figures, the company's ROIC has struggled to maintain positive territory, fluctuating between -4.7% and 2.3% over the last ten quarters, which indicates that the firm is currently failing to generate returns that exceed its cost of capital due to heavy non-recurring charges.
The erratic ROE, which plummeted to -93.0% in 2025Q2, highlights how legacy environmental and litigation-related accruals are eroding shareholder value. This trend suggests that until the company can stabilize its core operating margins, the ability to compound capital remains severely constrained by the ongoing burden of legacy obligations.
As evidenced by the provided quarterly data, the cash conversion cycle has trended upward from 73 days in 2023Q4 to 97 days in 2026Q1, reflecting increasing inefficiencies in inventory management and a potential slowdown in the company's ability to convert sales into cash amidst cyclical demand shifts.
The rise in days inventory outstanding to 120 days suggests that the company may be holding excess stock in anticipation of demand that has yet to materialize. This buildup of working capital, combined with a relatively stagnant asset turnover ratio of 0.19, indicates that the firm's capital-intensive manufacturing base is currently underutilized.
As reported in financial statements, the debt-to-equity ratio has surged to 20.33 in 2026Q1, a dramatic increase from 5.82 in 2023Q4, which signals that the company's financial leverage is becoming increasingly precarious as the equity base continues to shrink under the weight of persistent net losses.
The interest coverage ratio, which dipped to 0.57 in 2026Q1, warrants close monitoring as it suggests that the company may face difficulty servicing its debt obligations during periods of cyclical downturn. Investors should be concerned that the current leverage profile leaves little room for error should litigation-related cash outflows exceed current expectations.
The market's heavy reliance on Adjusted EBITDA as a primary valuation metric for this company is fundamentally flawed, as it consistently excludes significant cash-settled litigation and environmental remediation costs that are essential to understanding the firm's true, long-term cash-generative capacity and overall financial health.
By stripping out these 'non-core' expenses, the metric obscures the reality that these liabilities are recurring features of the business model rather than one-time events. Analysts should instead focus on free cash flow after all environmental and legal cash outflows to gain a more accurate picture of the company's actual ability to fund operations and return capital to shareholders.
Includes 30+ ratios · 14 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CC stock.
The Chemours Company's current P/E ratio is -7.4x. The historical average is 14.0x.
The Chemours Company's current EV/EBITDA is 20.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.0x.
The Chemours Company's return on equity (ROE) is -90.2%. The historical average is 25.3%.
Based on historical data, The Chemours Company is trading at a P/E of -7.4x. Compare with industry peers and growth rates for a complete picture.
The Chemours Company's current dividend yield is 2.75%.
The Chemours Company has 15.5% gross margin and -0.1% operating margin.
The Chemours Company's Debt/EBITDA ratio is 13.7x, indicating high leverage. A ratio above 4x may signal elevated financial risk.